Mulmit

Ultragenyx Pharmaceutical Inc.Ultragenyx Pharmaceutical Inc.

RARE Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31673,000,000-535,000,000-575,000,000-5.83
2024-12-31560,000,000-536,000,000-569,000,000-6.29
2023-12-31434,000,000-569,000,000-607,000,000-8.25
2022-12-31363,329,000-648,919,000-707,421,000-10.12
2021-12-31351,406,000-381,737,000-454,025,000-6.7

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-03Huizenga Theodore AlanSVP, Chief Accounting Officer161
2026-08-03Parschauer Karah HerdmanEVP and Chief Legal Officer1,900
2026-08-03Horn HowardChief Financial Officer4,696
2026-07-01Horn HowardChief Financial Officer4,698
2026-06-15Sanders Corazon (Corsee) D.2,000
2026-06-15Parschauer Karah HerdmanEVP and Chief Legal Officer1,899
2026-06-01Horn HowardChief Financial Officer4,653
2026-05-18SULIMAN SHEHNAAZ5,740
2026-05-14Ray Amrit7,751
2026-05-14Ray Amrit14,058
2026-05-14Sanders Corazon (Corsee) D.7,751
2026-05-14Sanders Corazon (Corsee) D.14,058

8-K events

FiledItems
2026-09-02Other events
2026-08-19Other events
2026-08-11Other events
2026-08-04Results of operations · Financial statements and exhibits
2026-05-18Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits
2026-04-02Other events
2026-03-30Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.